Thuja as an adjuvant medical management of juvenile recurrent laryngeal papillomatosis: our experience
DOI:
https://doi.org/10.18203/issn.2454-5929.ijohns20232231Keywords:
Laryngeal papillomatosis, Thuja, Human papilloma virusAbstract
A subgroup of recurrent respiratory papillomatosis, which is a larger clinical entity, is laryngeal papillomatosis. The vocal folds produce recurrent papillomata, which is a hallmark of the condition. The two most prevalent strains of human papillomavirus have been linked to the development of laryngeal papillomas, types 6 and 11. Distinctive presence of warty lesion on endoscopy is basis for clinical diagnosis. Surgery is the foremost treatment possibility, combined with adjuvant therapy such antiviral medications and immunomodulators. Thuja occidentalis, a tree whose leaves and leaf oil have anti-oxidant,antiviral,anti tumoral,anti inflammatory, antibacterial and antifungal properties. It has been extensively utilized to treat warts and condylomatous skin lesions. In this article, we go through the results of using Thuja as an adjuvant therapy for laryngeal papillomatosis in a 16-year-old female.
Metrics
References
Rivera GA, Morell F. Laryngeal Papillomas. In: StatPearls. Treasure Island (FL): StatPearls Publishing. 2022.
Carifi M, Napolitano D, Morandi M, Dall'Olio D. Recurrent respiratory papillomatosis: current and future perspectives. Ther Clin Risk Manag. 2015;11:731-8.
Fancello V, Melis A, Piana AF, Castiglia P, Cossu A, Sotgiu G et al. HPV Type 6 and 18 Coinfection in a Case of Adult-Onset Laryngeal Papillomatosis: Immunization with Gardasil. Case Rep Otolaryngol. 2015;916023:4.
Freedand GL, Derkay CS. Prevention of recurrent respiratory papillomatosis: role of HPV vaccination. Int J Pediatr Otorhinolaryngol. 2006;70(10):1799-803.
Villa LL, Costa RL, Petta CA. Prophylactic quadrivalent human papillomavirus (types 6, 11, 16, and 18) L1 virus-like particle vaccine in young women: a randomised double-blind placebo-controlled multicentre phase II efficacy trial. Lancet Oncol. 2005;1.
An overview of reducing risk of Hazards of HPV during laser excision. Standard Precautions by CDC. 2007. Available at: https://www.cdc.gov/infection control/guidelines/isolation. Accessed on 30 March, 2023.
Murali S, Saravanam PK, Dinakaran N. Role of thuja in the management of laryngeal papilloma. BMJ Case Rep. 2020;13(12):e238846.
Aljos F. A monograph of Cupressaceae and Sciadopitys. Surrey: Royal Botanic Gardens. “Flora of China” editorial board (1978). Flora of China. Science. 2005;7:318.
Chung IM, Praven N, Ahmad A. Composition of the essential oil and antioxidant activity of petroleum ether extract of Thuja koraiensis. Chem Asian J. 2011;23:3703-6.
Nazir MZ, Chandel S, Sehgal A. In vitro screening of antioxidant potential of Thuja occidentalis. J Chem Pharm Sci. 2016;8:283-6.
Dubey SK, Barta A. Antioxidant activities of Thuja occidentalis Linn. Asian J Pharm Clin Res. 2009;2:73-6.
Silva IS, Nicolau LAD, Sousa FBM, De Araújo S, Oliveira AP, Araújo TSL et al. Evaluation of anti-inflammatory potential of aqueous extract and polysaccharide fraction of Thuja occidentalis Linn. in mice. Int J Biol Macromol. 2017;105:1105-16.
Siveen KS, Kuttan G. Thujone inhibits lung metastasis induced by B16F-10 melanoma cells in C57BL/6 mice. Can J Physiol Pharmacol. 2011;89:691-703.
Saha S, Bhattacharjee P, Mukherjee S, Mazumdar M, Chakraborty S, Khurana A et al. Contribution of the ROS-p53 feedback loop in thuja induced apoptosis of mammary epithelial carcinoma cells. Oncol Rep. 2014;31:1589-98.
Sunila ES, Hamsa TP, Kuttan G. Effect of Thuja occidentalis and its polysaccharide on cell-mediated immune responses and cytokine levels of metastatic tumor-bearing animals. Pharm Biol. 2011;49:1065-73.
Sunila ES, Kuttan G. A preliminary study on antimetastatic activity of Thuja occidentalis L. in mice model. Immunopharmacol. Immunotoxicol. 2006;28:269-80.
EMEA-The European Agency for the Evaluation of Medicinal Products. Committee for Veterinary Medicinal Products-Thuja Occidentalis Available at: https://www.ema.europa.eu/en/documents/mrl-report/thuja-occidentalis-summary-report-committee-veterinary-medicinal-products_en.pdf. Accessed on 20 June 2023.
Hänsel R, Keller R, Rimpler H, Schneider G. Hagers Handbuch der Pharmazeutischen, 5th ed.; Springer: Berlin, Germnay. 1994;955-66.
Tegtmeier M, Harnischfeger G. Die Abhängigkeit des Thujongehaltes vom Extraktionsverfahren bei Zubereitungen aus Thujae herba. Pharmazie. 1994;49:56-8.
Kash N, Lee M, Kollipara R, Downing C, Guidry J, Tyring S. Safety and efficacy data on vaccines and immunization to human papillomavirus. J Clin Med. 2015;4(4):614-33.
